Skip to main content
. Author manuscript; available in PMC: 2018 Feb 21.
Published in final edited form as: Expert Opin Drug Deliv. 2008 Dec;5(12):1357–1376. doi: 10.1517/17425240802583421

Figure 4.

Figure 4

Dissolution profiles of ketoprofen-Eudragit® L100 physical mixture tablets (A), ketoprofen-Eudragit® L100 tablets from extrudates (B), and ketoprofen-Eudragit® L100 tablets using pulverized extrudates (C) in 0.1 M HCl for the first 2 hours, then in pH 6.8 Phosphate buffer for subsequent hours (M ± SD, n = 6).

Formulation 1(▲: drug/polymer ratio 1:1); Formulation 2 ( Inline graphic drug/polymer ratio 1:1.5); Formulation 3(◆: drug/polymer ratio 1:2).